-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EjgMFJGqyyRecCPxQydCE4cQhFwdple4qRnNWXmHOnZn8es+bNw4j7+AOdUWj2fe GYYkv3JII5zWB9QMZDs+1g== 0000912057-01-511958.txt : 20010502 0000912057-01-511958.hdr.sgml : 20010502 ACCESSION NUMBER: 0000912057-01-511958 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010426 ITEM INFORMATION: FILED AS OF DATE: 20010501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-21846 FILM NUMBER: 1619077 BUSINESS ADDRESS: STREET 1: 7825 FAY AVENUE SUITE 200 CITY: LAJOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 2129120930 MAIL ADDRESS: STREET 1: 7825 FAY AVENUE SUITE 200 CITY: LAJOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 8-K 1 a2047475z8-k.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act Date of Report (Date of earliest event reported) April 26, 2001 AETHLON MEDICAL, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 0-21846 13-3632859 (State or other jurisdiction (Commission File No.) (IRS Employer I.D. No.) of incorporation) 7825 Fay Avenue, Suite 200 LaJolla, California 92037 (Address of Principal Executive Offices) (858) 456-5777 Registrant's Telephone Number Item 4. Change in Registrant's Certifying Accountant. Aethlon Medical, Inc.'s (the "Company") former principal accountant, McGladrey & Pullen, LLP has declined to stand for re-election. On November 1, 2000, Freed, Maxick, Sachs & Murphy PC ("Freed Maxick"), the independent certified public accountants that audited the Company's financial statements for the years ended March 31, 2000 and 1999, merged into McGladrey & Pullen, LLP and subsequently McGladrey & Pullen, LLP became the Company's new auditor. Freed Maxick's reports on the Company's financial statements for the years ended March 31, 2000 and 1999 contained an unqualified opinion with an emphasis paragraph describing an uncertainty as to the Company's ability to continue as a going concern. McGladrey & Pullen, LLP has not issued any report on the Company's financial statements. During the two most recent fiscal years that Freed Maxick was engaged as the Company's independent certified public accountants, and through the date on which they merged with McGladrey & Pullen, LLP, there were no disagreements with Freed Maxick on any matter of accounting principles or practices, financial statement disclosure, audit scope or procedure which, if not resolved to its satisfaction, would have caused it to make reference to such disagreement in connection with its report. From the date of their engagement and through the date on which they declined to stand for re-election, there were no disagreements with McGladrey & Pullen, LLP on any matter of accounting principles or practices, financial statement disclosure, audit scope or procedure which, if not resolved to its satisfaction, would have caused it to make reference to such disagreement in connection with a report. On May 1, 2001, the Company engaged Squar, Milner, Reehl & Williamson, LLP as its principal accountant. The registrant's Board of Directors has approved the decision to engage the new accountants. The following exhibit is being filed with the Current Report on Form 8-K: Letter dated May 1, 2001 from McGladrey & Pullen, LLP addressed to the Securities and Exchange Commission pertaining to the statements made by the Company in response to Item 4 above. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. AETHLON MEDICAL, INC. Date: May 1, 2001 By: /s/James A. Joyce ------------------------------------------------ James A. Joyce, Chairman and Secretary EX-99.1 2 a2047475zex-99_1.txt EXHIBIT 99-1 Exhibit 99.1 May 1, 2001 Securities and Exchange Commission 450 Fifth Street, NW Washington, D.C. 20549 Re: Aethlon Medical, Inc. Ladies and Gentlemen: We have read and agree with the statements of Aethlon Medical Inc. (the "Company") included in Item 4 of the Company's Current Report on Form 8-K, dated May 1, 2001, except that we have no basis to agree or disagree with the Company's statement made in the fourth paragraph. /s/ MCGLADREY & PULLEN, LLP MCGLADREY & PULLEN, LLP -----END PRIVACY-ENHANCED MESSAGE-----